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Pharmaceutical preparationsAbstract Three simple, accurate and highly sensitive indirect spectrophotometric methods have
been developed for the determination of oxcarbazepine (OXC) in both pure and in pharmaceutical
preparations. The methods are based on the oxidation of oxcarbazepine by a known excess of
cerium(IV) in acid medium. This was followed by the determination of unreacted cerium(IV), which
oxidizes leuco dyes to colored dyes in the same acid medium. In method A, an unreacted cerium(IV)
oxidizes leuco crystal violet to crystal violet dye which is measured at 580 nm. A bluish-colored mal-
achite green with a maximum absorption at 610 nm is developed in method B. In method C, ceriu-
m(IV) oxidizes leuco xylene cyanol FF to blue colored xylene cyanol FF having absorption
maximum at 610 nm. In all these methods, the amount of cerium(IV) reacted corresponds to the
amount of OXC and the absorbance is found to decrease linearly with OXC concentration. Beer’s
law was obeyed in the concentration range of 0–2.5, 0–2.0 and 0–2.5 lg ml1 for methods A, B
and C, respectively, and the corresponding molar absorptivity values are 3.86 · 104, 4.41 · 104 and
2.16 · 104 l mol1cm1. All variables have been optimized and the results were statistically compared
with those of a literature method by employing the student’s t-test and F-test. No interference was
observed from excipients normally added to the tablets.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Oxcarbazepine (OXC), is chemically known as 10, 11-dihydro-
10-oxo-5H-dibenz (b,f) azepine-5-carboxamide is a keto analog
of carbamazepine and is an anticonvulsant andmood stabilizing
drug. OXC is known to exert antiepileptic activity by blockade
of voltage-dependent sodium channels in the brain. OXC is used
to treat seizures, several types of epilepsy and in management of
intractable trigeminal neuralgia. In view of its pharmacological
importance, considerable work has been done for the detection
and quantiﬁcation of OXC. Several researchers have reported
HPLC or GC (Mazzucchelli et al., 2007; Kimiskidis et al.,
S726 H.N. Deepakumari, H.D. Revanasiddappa2007; Chi et al., 2006; Klys et al., 2005; Mandrioli et al., 2003;
Levert et al., 2002; Rouan et al., 1994; Hartley et al., 1991;
Kumps, 1984; Menge and Dubois, 1983; Noirfalise and Collin-
ge, 1983; Von Unruh and Paar, 1985, 1986) methods for its
determination in human plasma, serum, urine and saliva. Other
techniques such as stripping voltammetry (Calvo et al., 2007)
and spectrophotometry (Ramaa et al., 2006; Gandhimathi and
Ravi, 2008) have also been reported for the assay of OXC in
pharmaceutical samples. The reported chromatographic tech-
niques (HPLC or GC) require expensive experimental set-up
and are not affordable in every laboratory for routine analysis.
The stripping voltammetric technique requires sophisticated
instrumentation, and involvement of scrupulous experimental
condition. The reported spectrophotometric methods are less
accurate and less sensitive. Thus, there is a need to develop sen-
sitive, accurate and cost-effectivemethods for its determination.
The aim of the present study is to develop a simple, sensitive and
validated spectrophotometric methods for the analysis of OXC
in pure form and in pharmaceutical samples using cerium(IV),
as an oxidant and leuco crystal violet, leuco malachite green
and leuco xylene cyanol FF as the chromogenic reagents. The
developed methods were validated for linearity, accuracy and
precision.
2. Materials and reagents
2.1. Apparatus
All absorbance measurements were performed using a Systron-
ics Model 166 digital spectrophotometer provided with 1-cm
matched quartz cells. An Elico 120 digital pH meter was used
for pH measurements.
2.2. Reagents and standards
All chemicals and reagents used were of analytical reagent grade
and distilled water was used throughout the investigation.
2.2.1. Standard OXC solution
Pharmaceutical grade OXC was obtained from Cipla India
Ltd., Mumbai, India, as a gift sample. A stock standard solu-
tion equivalent to 100 lg ml1 of OXC was prepared by dis-
solving 10 mg of the pure drug in 5 ml methanol and diluted
to the volume in a 100 ml calibrated ﬂask using distilled water.
Working standard was prepared from the stock solution.
Pharmaceutical formulations of oxcarbazepine such as OX-
RATE 150 mg (Wockhard, India) and OXETOL 150 mg (Sun
Pharma, India) were purchased from local markets.
2.2.2. Standard cerium(IV) solution (1000 lg ml1)
It was prepared by dissolving 0.3916 g of ammonium ceric ni-
trate (BDH, Anal R) in 100 ml water containing 0.5 ml of conc.
HNO3. A working standard solution was prepared by a suitable
dilution of a standard solution as and when required.
2.2.3. Leuco crystal violet (LCV, 0.025%)
It was prepared by adding 250 mg of LCV (Sigma–Aldrich,
Steinhein, Germany), 200 ml of water and 3 ml of 85% phos-
phoric acid to 1000 ml volumetric ﬂask and shaken gently until
the dye dissolved. The contents of the ﬂask were then diluted
to the mark with distilled water. The reagent was stable for
more than 2 months.2.2.4. Leuco malachite green (LMG, 0.05%)
It was prepared by adding 5 mg of LMG (Sigma–Aldrich,
Steinhein, Germany), 20 ml of water and 0.5 ml of 85% phos-
phoric acid to 100 ml calibrated ﬂask and shaken gently until
the dye dissolved (phosphoric acid was added to dissolve the
dye completely and to keep the solution stable for a longer
time). The contents of the ﬂask were diluted to 100 ml with
water. The reagent was stable for more than 2 months.
2.2.5. Leuco xylene cyanol FF (LXCFF, 0.1%)
It was prepared by dissolving 100 mg of Xylene cyanol FF in
25 ml of water containing 0.7–0.8 g of zinc dust and 2 ml of
1 M acetic acid, stirred well and kept aside for 20 min, and
then the resulting solution was diluted to 100 ml with water
(ﬁlter if necessary).
2.2.6. Sulfuric acid
0.05 M and 0.5 M.
2.2.7. Acetate buffer (pH-4.0)
Itwas prepared by dissolving 13.6 g of sodiumacetate trihydrate
in 80 ml of water. The solution pH was adjusted to 4.0 with ace-
tic acid, and the mixture was diluted to 100 ml with water.
2.3. Procedures
2.3.1. Preparation of calibration graph
2.3.1.1. Method A. Aliquots of pure OXC solution (0–2.5 ml;
10 lg ml1) were transferred into a series of 10 ml calibrated
ﬂasks. To this, 0.6 ml of cerium(IV) [50 lg ml1] and 0.5 ml
each of 0.5 M sulfuric acid and 0.025% LCV were added,
and the reaction mixture was kept in a water bath (40 C)
for 5 min, cooled to room temperature and the contents were
diluted to the mark with acetate buffer of pH-4.0 and mixed
well. The absorbance was measured at 580 nm against distilled
water blank.
2.3.1.2. Method B. Into a series of 10 ml calibrated ﬂasks were
placed 0–2.0 ml (10 lg ml1) of OXC, 0.6 ml of cerium(IV)
[50 lg ml1], 0.5 ml of 0.5 M sulfuric acid and 0.5 ml of
0.05% LMG. The reaction mixture was kept in a water bath
for 20 min (60 C) and cooled to room temperature. A vol-
ume of 3 ml of acetate buffer (pH-4.0) was added to each ﬂask
and then the contents were diluted to the mark with distilled
water and mixed well. The absorbance of the formed malachite
green was measured at 610 nm.
2.3.1.3. Method C. Accurately measured volume of the drug
solution equivalent to 0–2.5 lg ml1 ﬁnal solution of OXC
was transferred into a series of 10 ml calibrated ﬂasks. To this,
0.8 ml of cerium(IV) and 0.5 ml each of the 0.05 M H2SO4 and
0.1% LXCFF were added. The reaction mixture was kept in a
water bath (90 C) for 10 min; after being cooled to room
temperature, the contents were diluted to the mark with
acetate buffer (pH-4.0) and mixed well. The absorbance of
the formed xylene cyanol FF dye was measured at 610 nm
against distilled water.
In each method, a blank was prepared similarly omitting
the drug and its absorbance was measured against distilled
water. The decrease in absorbance corresponding to the con-
sumed cerium(IV) and in turn, to the drug concentration,
was obtained by subtracting the absorbance of the blank
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was drawn by plotting the difference in absorbance (test and
blank solution) of the formed dye against the concentration
of the OXC (Fig. 1). The amount of the OXC was determined
from the concurrent calibration curve or regression equation.
2.4. Procedure for tablets
Twenty tablets were weighed accurately and ground into ﬁne
powder. A quantity of the powder equivalent to 10 mg of
OXC was weighed accurately into a 100 ml calibrated ﬂask
and 50 ml methanol was added. The content was shaken for
about 30 min; the volume was diluted to the mark with water
and mixed well and ﬁltered using a Whatman No.41 ﬁlter pa-
per. An appropriate dilute solution was subjected to analysis
by the procedures described above.
3. Results and discussion
In an acid medium, cerium(IV) quantitatively oxidizes LXCFF
into xylene cyanol FF, which shows maximum absorption at
610 nm (Revanasiddappa and Kiran Kumar, 2002). In a simi-
lar reaction, cerium(IV) oxidizes leuco malachite green (LMG)
to malachite green (Revanasiddappa and Dayananda, 2007).
Both methods were used to determine micro amounts of ceriu-
m(IV) spectrophotometrically. In this work, known but exces-
sive amount of cerium(IV) was utilized to oxidize OXC inFigure 1 Calibration curves for OXC.
Scheme 1 Probablesulfuric acid medium with a sufﬁcient heating, and the unre-
acted cerium(IV) was determined by reacting it with LCV
(method A), LMG (method B) and LXCFF (method C) in
the same experimental conditions. In each method, absorbance
of the formed dye was measured at speciﬁed wavelengths. This
has been the basis for the determination of OXC in pure and in
pharmaceutical samples.
The reaction pathways of all the methods are shown in
Scheme 1. Based on the above observations, simple spectropho-
tometric methods to the determination of OXC were developed
and validated as per the current ICH guidelines (International
Conference on Harmonization, 1996).
The various experimental parameters, which inﬂuence the
formation of the colored dye, were optimized.
3.1. Effect of time
The inﬂuence of the reaction time on the absorbance of the prod-
uct was studied on 1 lg ml1 of OXC with different chromo-
genic reagents as mentioned under methods A, B and C. The
optimum reaction time was found to be 5, 20 and 10 min for
methods A, B and C, respectively, for the complete formation
of dye.
3.2. Effects of acidity and temperature
The oxidation of LCV, LMG and LXCFF by cerium(IV) was
studied. Of the various acids (sulfuric, hydrochloric and phos-
phoric) studied, sulfuric acid was found to be the best acid for
the system. Constant absorbance readings were obtained in the
0.1–1.5 ml range of 0.5 M sulfuric acid [pH-1.0–2.3] at a tem-
perature 40 C for 5 min for method A or 60 C for 20 min
for method B and 0.05 M sulfuric acid [(or) pH-1.4–3.9] at
90 C for 10 min for method C. An increase of the pH above
3.9 markedly affected the stability and sensitivity of the dye.
Color development did not take place below pH-1.0 for meth-
ods A and B and pH-1.4 in method-C. Hence, a volume of
0.5 ml of 0.5 M sulfuric acid was used in methods A and B,
and 0.5 ml of 0.05 M sulfuric acid in a total volume of 10 ml
was used in method C.
3.3. Effects of reagent concentration and buffer media
The optimum concentration of LCV, LMG and LXCFF lead-
ing to maximum color stability was found to be 0.5 ml each of
0.025% LCV, 0.05% LMG and 0.1% LXCFF reagents perreaction scheme.
Figure 2 Effect of pH on the absorbance of CV, MG and XCFF
dyes.
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tively. The absorbance values were measured in the pH range
of 3.7–4.3 for LCV and LMG (methods A and B), and in pH
3.5–4.8 for LXCFF (method C). This could be achieved by
adding acetate buffer of pH-4.0 in all the methods (A, B andTable 2 Evaluation of accuracy and precision.
Method OXC taken
(lg ml1)
OXC founda
(lg ml1)
RE (%)
Method A 0.5 0.49 1.21
1.0 1.02 1.68
2.0 2.01 0.28
Method B 0.5 0.50 0.58
1.0 0.99 0.57
2.0 2.01 0.26
Method C 0.5 0.51 0.94
1.0 1.02 2.14
2.0 2.00 0.21
RE: relative error; SD: standard deviation; SEM: standard error of mean
a Mean value of ﬁve determinations.
b At the 95% conﬁdence level for 4 degrees of freedom.
Table 1 Optical characteristic and statistical data of the regression
Parameter Method A
kmax, nm 580
Beer’s law range (lg ml1) 0–2.5
Molar absorptivity (e), (l mol1cm1) 3.86 · 104
Sandell sensitivity (lg cm2) 0.0065
Intercept (a) 0.0019
Slope (b) 0.1563
Correlation coeﬃcient (r) 0.999
Sa 0.0074
Sb 0.0035
LOQ(lg ml1) 0.1152
LOD(lg ml1) 0.0380
Y= a+ bx, where c is the concentration of OXC in lg ml1 and Y is the
intercept, Sb is the standard deviation of the slope.C). Intensity of the colored dye may be affected by a change
in the above pH range. The formed colored dye was stable
for more than a week in all the methods. The effect of pH
on the color system is shown in Fig. 2.
3.4. Method validation
The proposed methods have been validated for linearity, sensi-
tivity, precision, accuracy, selectivity and recovery.
3.4.1. Linearity and sensitivity
Under optimum conditions, a linear relation was obtained be-
tween the absorbance and concentration of OXC in the range
0–2.5 lg ml1. The calibration graph is described by the equa-
tion: Y= a+ bx, where Y= absorbance, a= intercept,
b= slope and x= concentration, obtained by the method of
least squares. The correlation coefﬁcient (r), intercept (a) and
slope (b) for the calibration data and sensitivity parameters,
such as apparent molar absorptivity and Sandell sensitivity
values, the limits of detection and quantiﬁcation calculated
as per the current ICH guidelines (International Conference
on Harmonization, 1996) are compiled in Table 1.
The limits of detection (LOD) and quantiﬁcation (LOQ)
were calculated according to the same guidelines using the for-
mulas: LOD= 3.3r/s and LOQ= 10r/s where r is the stan-SD SEM RSD (%) ROEb (%)
0.008 0.002 0.873 ±0.872
0.008 0.003 0.814 ±0.813
0.016 0.006 0.776 ±0.776
0.006 0.002 1.103 ±1.102
0.002 0.001 0.224 ±0.224
0.005 0.002 0.271 ±0.271
0.004 0.002 0.789 ±0.788
0.007 0.003 0.657 ±0.657
0.010 0.004 0.486 ±0.486
; RSD: relative standard deviation; ROE: range of error.
equation.
Method B Method C
610 610
0–2.0 0–2.5
4.41 · 104 2.16 · 104
0.0057 0.0117
0.0032 0.0120
0.1655 0.1843
0.999 0.997
0.0156 0.0158
0.0059 0.0076
0.1950 0.0464
0.0644 0.0153
absorbance at the respective kmax, Sa is the standard deviation of the
Table 4 Results of recovery experiments via the standard addition technique.
Tablet brand name Method A Method B Method C
OXC
tablet
(lg ml1)
Pure OXC
added
(lg ml1)
Total
found
(lg ml1)
Pure OXC
recovereda
(%± SD)
Pure OXC
added
(lg ml1)
Total
found
(lg ml1)
Pure OXC
recovereda
(%± SD)
Pure OXC
added
(lg ml1)
Total
found
(lg ml1)
Pure OXC
recovereda
(%± SD)
OXRATE 150 mg 1.0 0.5 1.50 100.45 ± 0.181 0.5 1.52 101.71 ± 0.193 0.5 1.506 101.18 ± 0.186
1.0 1.0 1.99 99.66 ± 0.09 1.0 2.01 100.82 ± 0.145 1.0 2.008 100.83 ± 0.196
1.0 1.5 2.52 101.09 ± 0.181 1.5 2.51 100.78 ± 0.097 1.5 2.489 99.26 ± 0.143
a Mean value of three measurements.
Table 3 Results of determination of OXC in tablets and statistical comparison with the reference method.
Tablet brand name Nominal amount
(mg per tablet)
Founda (% of nominal amount ± SD)
Reference method Method A Method B Method C
OXRATE (Wockhard) 150 mg 98.6 ± 0.8 100.16 ± 0.42 99.37 ± 0.33 99.82 ± 0.35
t= 2.44, F= 1.41 t= 2.14, F= 5.89 t= 2.57, F= 5.31
OXETOL (Sun pharma) 150 mg 98.6 ± 0.8 99.86 ± 1.2 99.93 ± 0.99 100.2 ± 0.36
t= 1.252, F= 1.413 t= 1.52, F= 1.53 t= 2.64, F= 4.97
Tabulated t and F-values at 95% conﬁdence level are 2.77 and 6.39, respectively.
a Mean value of ﬁve determinations.
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is the slope of calibration curve.
3.4.2. Accuracy and precision
To evaluate the accuracy and precision of the methods, pure
drug solution at three different levels (within the working lim-
its) was analyzed, each determination being repeated ﬁve
times. The relative error (%) and relative standard deviation
(%) were less than 2.0 and indicate the high accuracy and pre-
cision of the methods (Table 2).
3.4.3. Application to analysis of commercial samples
To check the validity of the proposed methods, OXC was
determined in some commercial formulations. The result ob-
tained from the determination is in close agreement between
the results obtained by the proposed methods and the label
claim. Statistical analysis of the results using Student’s t-test
for accuracy and F-test for precision revealed no signiﬁcant
difference between the proposed methods and the literature
method (Ramaa et al., 2006) at the 95% conﬁdence level with
respect to accuracy and precision (Table 3). The calculated t-
and F-values (Table 3) did not exceed the tabulated values
(t= 2.77 and F= 6.39).
3.4.4. Recovery study
The accuracy and precision of the proposed methods were fur-
ther ascertained by performing recovery studies. Pre-analyzed
tablet powder was spiked with pure drug at three different con-
centrations and the total was found by the proposed methods.
Each determination was repeated three times. The recovery of
the pure drug added was quantitative and revealed that co-for-
mulated substances such as talc, dextrose, alginate, acacia, etc.
did not interfere in the determination. The results of recovery
study are given in Table 4.4. Conclusions
Three simple, accurate, precise and highly sensitive spectro-
photometric methods were developed for the determination
of oxcarbazepine in bulk drug and in tablets. The methods rely
on the use of simple and cost-effective reagents in all the three
methods. All methods developed are highly sensitive when
compared to highly expensive techniques such as HPLC or
GC and other reported spectrophotometric methods. Thus,
the proposed methods can be used for routine analysis in lab-
oratories and for quality control purposes.Acknowledgements
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